US Marijuana Party

Tuesday, December 21, 2004

Cannabis hopes bolster drugs firm

A prescription cannabis drug made by UK biotech firm GW Pharmaceuticals is set to be approved in Canada.
"We are delighted to receive this qualifying notice from Health Canada and look forward to receiving regulatory approval for Sativex in Canada in the early part of 2005," said GW Pharma executive chairman Dr Geoffrey Guy.


Post a Comment

<< Home